Kalos Management, Inc. Merck & Co., Inc. Transaction History

Kalos Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$102.94 - $114.86 $62,175 - $69,375	604 New	604 $64,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $732,808 - $863,172	-10,642 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $15,789 - $17,523	220 Added 2.11%	10,642 $865,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $3,439 - $3,898	-47 Reduced 0.45%	10,422 $843,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $140 - $160	2 Added 0.02%	10,469 $859,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $33,264 - $46,105	525 Added 5.28%	10,467 $814,000
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $7,059 - $7,966	-91 Reduced 0.91%	9,942 $833,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $158,187 - $184,801	2,265 Added 29.16%	10,033 $846,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $163,373 - $186,337	-2,348 Reduced 23.21%	7,768 $646,000
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $659,967 - $765,882	10,116 New	10,116 $726,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $583,592 - $686,269	-10,116 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $11,313 - $13,149	-222 Reduced 2.15%	10,116 $590,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $533,647 - $637,234	10,338	10,338 $569,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.